4
Changes in Ownership
REPLIGEN CORP Filed Acc 0001628280-26-063572
Chief Executive Officer sold 12,946 shares at $190.00 ($2,459,740)
- Chief Executive Officer acquired 12,946 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Loeillot Olivier Chief Executive Officer | 2026-09-24 | Option exercise 10b5-1 | +8,404 | $154.96 | $1,302,284 | 56,773 | D |
| Loeillot Olivier Chief Executive Officer | 2026-09-24 | Sale 10b5-1 | −8,404 | $190.00 | $1,596,760 | 48,369 | D |
| Loeillot Olivier Chief Executive Officer | 2026-09-24 | Option exercise 10b5-1 | +4,542 | $155.38 | $705,736 | 52,911 | D |
| Loeillot Olivier Chief Executive Officer | 2026-09-24 | Sale 10b5-1 | −4,542 | $190.00 | $862,980 | 48,369 | D |
| Derivatives | |||||||
| Loeillot Olivier Chief Executive Officer | 2026-09-24 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,404 | 12,607 | D | ||
| Loeillot Olivier Chief Executive Officer | 2026-09-24 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,542 | 9,085 | D | ||
| Open-market sales · 12,946 sh · avg $190.00 · $2,459,740 | |||||||
Loading xslF345X06/wk-form4_1790366980.xml…